Attentive Science Welcomes Thomas O'Neill
Mar 11, 2025
2 minutes Read
General
We are thrilled to welcome Thomas O’Neill to Attentive Science as our Executive Vice President of Commercial Services and Client Relations. With a diverse background spanning toxicology, study management, and business development, Thomas brings a wealth of experience to our team.
Tom held a key leadership role as Director of Commercial Services and Senior Business Development Director for nearly a decade at his previous company, where he successfully built client relationships and drove commercial growth. Additionally, as a seasoned Study Director and former Assistant Director of Toxicology, he has extensive experience in nonclinical safety assessment and regulatory requirements. His deep understanding of both the scientific and business aspects of our field makes him an invaluable addition to our leadership team.
In his new role, Tom will focus on strengthening client partnerships, expanding service offerings, and continuing to elevate Attentive Science. His expertise aligns perfectly with Attentive Science’s commitment to delivering personalized, high-quality research services in the biotech, pharma, agrochemical, and animal health industries.
A Word from Thomas O’Neill
“I’m very excited to be joining the Attentive Science team and bring my 36 years of CRO experience to help clients streamline their preclinical drug development programs in order to get valuable medicines to patients as soon as possible. I really am grateful to be part of such a passionate and talented team and am looking forward to continuing the mission of providing high quality research services to all our clients.”
We are excited for the expertise and leadership Thomas brings to our team and look forward to the impact he will make.
Please join us in giving him a warm welcome to the group of industry Veterans at Attentive Science team!
Social Networks
Tags
Related Blogs
Lab Technicians: The Unsung Heroes Driving Research Success
At Attentive Science, our laboratory technicians are more than technical experts; they are collaborators and real-time problem-solvers
2 mins read
Feb 5, 2026
The Future of CROs: Not AI vs Humans, But AI With Humans.
As 2025 closed, one question dominated life sciences: Will artificial intelligence (AI) replace humans in drug development?
3 mins read
Jan 12, 2026
News Flash: Dr. Basel Assaf Joins Attentive Science Limited
Attentive Science is proud to welcome Dr. Basel Assaf, BVSc, PhD, DACVP, DABT, FIATP as our new Vice President of Toxicology and Pathology.
2 mins read
Sep 24, 2025
News Flash: Brad Wahle Joins Attentive
Attentive Science is thrilled to welcome Brad Wahle, M.S., DABT as our new Associate Director of Toxicology!
2 mins read
Feb 7, 2025